An ovation ix abdominal stent graft system was implanted to treat an abdominal aortic aneurysm.The initial procedure went without issue and the post-operative ct showed no signs of a type 1a endoleak.One month post-op, the patient returned for a routine follow-up where physician observed a type 1a endoleak.A re-intervention was done where physician implanted a palmaz stent and successfully resolved the type 1a endoleak.As of the date of this report, there have been no additional patient sequelae reported.
|
Based on the description of the event and provided medical records, clinical assessment confirmed the reported events of the type ia endoleak, and secondary procedure.Additionally, clinical assessment identified type ii endoleaks at the ima and l4 lumbar artery, as well as infolding of the sealing ring.The most likely cause of the loss of seal is the infolding of the sealing ring in an angulated proximal neck (juxtarenal angulation of 77 degrees, off-label).There were no known procedure or user related issues or cautionary product use conditions related to this event.Associated clinical harms for this device included: type ia endoleak; secondary endovascular procedure of placing a self expanding stent across the sealing ring.The final patient disposition was discharged home on post operative day one in improved condition.There was no device related issue involving the type ii endoleak the cautionary product use conditions such as a patent ima and lumbar arteries, likely contributed to the clinical harm.The review of manufacturing lot confirmed all devices met specifications prior to release.No additional investigations of this reported complaint are planned.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
|